The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers

Abstract

Introduction Europe is an important focus for compiling accurate and up-to-date world cancer statistics owing to its large share of the world's total cancer burden. This article presents incidence and mortality estimates for 25 major cancers across 40 individual countries within European areas and the European Union (EU-27) for the year 2020. Methods The estimated national incidence and mortality rates are based on statistical methodology previously applied and verified using the most recently collected incidence data from 151 population-based cancer registries, mortality data and 2020 population estimates. Results Estimates reveal 4 million new cases of cancer (excluding non-melanoma skin cancer) and 1.9 million cancer-related deaths. The most common cancers are: breast in women (530,000 cases), colorectum (520,000), lung (480,000) and prostate (470,000). These four cancers account for half the overall cancer burden in Europe. The most common causes of cancer deaths are: lung (380,000), colorectal (250,000), breast (140,000) and pancreatic (130,000) cancers. In EU-27, the estimated new cancer cases are approximately 1.4 million in males and 1.2 million in females, with over 710,000 estimated cancer deaths in males and 560,000 in females. Conclusion The 2020 estimates provide a basis for establishing priorities in cancer-control measures across Europe. The long-established role of cancer registries in cancer surveillance and the evaluation of cancer control measures remain fundamental in formulating and adapting national cancer plans and pan-European health policies. Given the estimates are built on recorded data prior to the onset of coronavirus disease 2019 (COVID-19), they do not take into account the impact of the pandemic.

Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: A French comprehensive multicentre ambispective observational cohort study (CAPANCOVID)

“…Pancreatic adenocarcinoma (PA) is the most lethal gastrointestinal cancer and the fourth cause of cancer-related deaths in Europe with few therapeutic perspective 1 , 2 . The severity of Coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome – Coronavirus 2 (SARS-CoV2) required most countries to take measures to contain the pandemic in 2020.…”

Two Decades of Active Surveillance for Prostate Cancer in a Single-Center Cohort: Favorable Outcomes after Transurethral Resection of the Prostate

“…Prostate cancer (PCa) is the most commonly diagnosed cancer in men and third most common cause of cancer death [ 1 ]. Treatment options for patients with low-grade PCa include radical prostatectomy, radiotherapy, or active surveillance.…”

Precursor Lesions of Gallbladder Carcinoma: Disease Concept, Pathology, and Genetics

“…Gallbladder cancer is the 22nd most prevalent and 17th most deadly cancer worldwide [ 1 , 2 , 3 ]. It is noted to disproportionately affect females more than males, perhaps due to the higher propensity of females to have gallstone disease [ 4 ].…”